Clinical trial
A Prospective Observational Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
NCT04650152 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 27, 2020
- Completion date
- November 12, 2021
- Enrollment
- 1,000 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.